Today In Biotech: Palatin Technologies (PTN), Omeros Corporation (OMER), Biocept (BIOC), MannKind (MNKD), Synergy Pharmaceuticals (SGYP)
Palatin Technologies Climbs As Female Viagra Is Approved Palatin Technologies, Inc. (NYSEMKT: PTN) Palatin Technologies is having a great day in the market after Sprout Pharmaceuticals received FDA approval for Addyi; a female sexual dysfunction medication that’s being referred to as “female Viagra”. While Palatin Technologies is in no way connected to Sprout Pharmaceuticals, . … Read more